Tolerance to Endotoxin in an Animal Model of Acute Pancreatitis Is Associated with Improved Cellular Immune Function

  • P. J. Curley
  • R. G. Holzheimer
  • M. Nestor
  • I. Saporoschetz
  • J. A. Mannick
  • M. L. Rodrick
Conference paper

Abstract

Endotoxin is thought to play a central role in the development of irreversible multi-organ failure in patients with septic shock which is the largest cause of mortality in the intensive care setting [1]. Antiserum to the central core of endotoxin has been shown to reduce mortality in septic patients from 39% to 22% [2] lending further credence to the central role of endotoxin in the pathogenesis of multi-organ failure. There is some evidence that endotoxin is involved in the pathogenesis of necrotizing pancreatitis also. Windsor et al. [3] have demonstrated high endotoxin levels in the serum and ascitic fluid of a majority of patients with pancreatic necrosis. Deitch et al. [4] have shown that the absence of bile from the gut of mice leads to increased bacterial translocation and higher levels of bacterial contamination in the caecum thus lending further support to the concept of disimpaction of gallstones for the urgent treatment of gallstone pancreatitis [5].

Keywords

Placebo Pancreatitis Penicillin Carbon Monoxide Prostaglandin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Parillo JE (1990) Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction and therapy. Annals Intern Med 113: 227–242Google Scholar
  2. 2.
    Ziegler EJ, McCutchan JA, Fierer J et al. (1982) Treatment of gram negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med 307:1225–1230PubMedCrossRefGoogle Scholar
  3. 3.
    Windsor SA, Fearon KC, Boss JA, Barclay GR, Smyth E et al. (1993) Role of serum endotoxin and antiendotoxin core antibody levels in predicting the development of multiple organ failure in acute pancreatitis. Br J Surg 88:1942–1946Google Scholar
  4. 4.
    Deitch EA, Sittig K, Li M, Berg R et al. (1990) Obstructive jaundice promotes bacterial translocation from the gut. Am J Surg 159:79–84PubMedCrossRefGoogle Scholar
  5. 5.
    Neoptolemos JP, Carr-Locke DL, Leese T, James D (1987) Acute cholangitis in association with acute pancreatitis: incidence, clinical features and outcome in relation to ERCP and endoscopic sphincterotomy. Br J Surg 74:1103–1106PubMedCrossRefGoogle Scholar
  6. 6.
    Fossard DP, Kakkar VV (1974) The Limulus test in experimental and clinical endotoxaemia. Br J Surg 61:798–804PubMedCrossRefGoogle Scholar
  7. 7.
    Foulis AK, Murray WR, Galloway D, McCartney AC et al. (1982) Endotoxaemia and complement activation in acute pancreatitis in man. Gut 23:656–661PubMedCrossRefGoogle Scholar
  8. 8.
    Kivilaakso E, Valtonen VV, Malkamaki M, Palmu A et al. (1984) Endotoxaemia and acute pancreatitis: correlation between the severity of the disease and the anti-bacterial common antigen antibody titre. Gut 25:1065–1070PubMedCrossRefGoogle Scholar
  9. 9.
    Pierrakakis S, Xepapadakis G, Mega AM, Megas T et al. (1990) Studio sull’-endotossinemia nella pancreatite acuta con l’impiego del limulus amebocyte lysate test (LAL test). Minerva Chir 45:295–301PubMedGoogle Scholar
  10. 10.
    Fugger R, Hamilton G, Rogy M, Herbst F et al. (1990) Prognostic significance of endotoxin determination in patients with severe intraabdominal infection. J Infect Dis 161:1314–1315PubMedCrossRefGoogle Scholar
  11. 11.
    Exley AR, Leese T, Holliday MR, Swann RA, Cohen J (1992) Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pan­creatitis. Gut 1992;33(8):1126–1128CrossRefGoogle Scholar
  12. 12.
    Florholmen J, Lindai S, Rokke O, Olsen R et al. (1988) Effects of endotoxin on the pancreatic ultrastructure APMIS 96:991–996Google Scholar
  13. 13.
    Banks RE, Evans SW, Alexander D, McMahon MJ et al. (1990) Is fatal acute pancreatitis a consequence of excessive leukocyte stimulation? Cytokine 3: 1–6CrossRefGoogle Scholar
  14. 14.
    Leser HG, Gross V, Scheinbenbogen C, Heinisch A, Salm R et al. (1991) Elevation of serum interleukin-6 concentration precedes acutephase response and reflects severity in acute pancreatitis. Gastroenterology 101:782–785PubMedGoogle Scholar
  15. 15.
    Heath DI, Cruickshank A, Gudgeon M, Jehanli A et al. (1993) Role of inter­leukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 34:41–45PubMedCrossRefGoogle Scholar
  16. 16.
    Sanchez-Cantu L, Rode HN, Christou NV (1989) Endotoxin tolerance is asso­ciated with reduced secretion of tumour necrosis factor. Arch Surg 124:1432–1436PubMedCrossRefGoogle Scholar
  17. 17.
    He W, Fong Y, Marano MA, Gershenwald JE et al. (1992) Tolerance to endotoxin prevents mortality in infected thermal injury: association with attenu­ated cytokine responses. J Infect Dis 165:859–864PubMedCrossRefGoogle Scholar
  18. 18.
    Gillis B, Ferm MM, Ou W, Smith KA (1978) T-cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol 120:2027–2032PubMedGoogle Scholar
  19. 19.
    Apostolou K, Nasbeth DC, Shapiro DH, Ryak P (1965) Immunity to the lethal effects of acute pancreatitis. Surg Forum 16:382–384PubMedGoogle Scholar
  20. 20.
    Peterson LM, Collins JJ, Wilson RE (1968) Acute pancreatitis occurring after operation. Surg Gynecol Obstet 23–28Google Scholar
  21. 21.
    Antal L, Kavai M, Szabo G, Sonkoly I et al. (1980) Immunological investigations in acute and chronic human pancreatitis. Digestion 20:100–105PubMedCrossRefGoogle Scholar
  22. 22.
    Burleson DG, Mason AD, McManus AT, Pruitt BA (1988) Lymphocyte phenotype and function changes in burn patients after intravenous IgG therapy. Arch Surg 123:1379–1382PubMedCrossRefGoogle Scholar
  23. 23.
    White TT, Morgan A, Hopton D (1970) Postoperative pancreatitis: a study of seventy cases. Am J Surg 120:132–135PubMedCrossRefGoogle Scholar
  24. 24.
    Bragg LE, Thompson JS, Burnett DA, Hodgson PE et al. (1985) Increased incidence of pancreas-related complications in patients with postoperative pan­creatitis. Am J Surg 150:694–697PubMedCrossRefGoogle Scholar
  25. 25.
    Garcia-Sabrido JL, Valdecantos E, Bastida E, Tellado JM (1989) The anergic state as a predictor of pancreatic sepsis. Zentralbl Chir 114:114–120PubMedGoogle Scholar
  26. 26.
    Richardson RP, Rhyne CD, Fong Y, Hesse DG, Tracey KJ et al. (1989) Peripheral blood leukocyte kinetics following in vivo lipopolysaccharide (LPS) administration to normal human subjects. Ann Surg 210(2):239–245PubMedCrossRefGoogle Scholar
  27. 27.
    Gough DB, Moss NM, Jordan AA, Grbic JT, Rodrick ML, Mannick JA (1988) Recombinant interleukin-2 (rIL-2) improves immune response and host resistance to septic challenge in thermally injured mice. Surgery 104:292–299PubMedGoogle Scholar
  28. 28.
    Horgan PG, Mannick JA, Dubravec DB, Rodrick ML (1990) Effect of low dose recombinant interleukin-2 plus indomethacin on mortality after sepsis in a murine burn model. Br J Surg 77:401–404PubMedCrossRefGoogle Scholar
  29. 29.
    Curran RD, Billiar TR, West MA, Bentz BG et al. (1988) Effect of interleukin 2 on Kupffer cell activation. Arch Surg 123:1373–1378PubMedCrossRefGoogle Scholar
  30. 30.
    Callery MP, Kamei T, Flye W (1990) Kupffer cell blockade increases mortality during intra-abdominal sepsis despite improving systemic immunity. Arch Surg 125:36–41PubMedCrossRefGoogle Scholar
  31. 31.
    Karimgani I, Porter KA, Langevin E, Banks PA (1992) Prognostic factors in sterile pancreatic necrosis. Gastroenterology 103:1636–1640PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • P. J. Curley
  • R. G. Holzheimer
  • M. Nestor
  • I. Saporoschetz
  • J. A. Mannick
  • M. L. Rodrick

There are no affiliations available

Personalised recommendations